Haloperidol Teva Uk

Haloperidol Teva Uk is a prescription‑only medication that contains the active ingredient haloperidol. It is supplied in an oral dosage form, with the specific strength not disclosed in the product listing. The drug belongs to the butyrophenone class of antipsychotics and is marketed in the United Kingdom as a generic product. It is intended for use under medical supervision and is regulated by the European Union pharmaceutical standards.

Haloperidol Teva Uk is indicated for several psychiatric conditions where dopamine blockade can reduce symptoms.

- Schizophrenia, including chronic and acute phases. - Acute psychotic episodes associated with mood disorders. - Manic episodes in bipolar disorder. - Tourette syndrome and related tic disorders. - Severe agitation requiring rapid symptom control.

Side effects of haloperidol may vary in frequency and severity, ranging from mild to potentially serious.

Common: - Drowsiness or sedation. - Extrapyramidal symptoms such as tremor or rigidity. - Dry mouth and increased salivation. - Constipation or gastrointestinal discomfort. - Weight gain or changes in appetite. - Orthostatic dizziness or light‑headedness.

Serious: - Neuroleptic malignant syndrome. - Tardive dyskinesia with involuntary movements. - Severe hypotension or cardiac arrhythmias. - Seizures. - Elevated prolactin levels causing galactorrhea. - Severe allergic reactions (e.g., rash, angioedema).

When prescribing Haloperidol Teva Uk, clinicians should consider several precautionary factors to minimize risk.

- Use cautiously in elderly patients, especially those with dementia‑related psychosis. - Assess cardiovascular status; haloperidol can affect heart rhythm. - Monitor liver and kidney function in patients with organ impairment. - Evaluate for a history of seizures or movement disorders. - Discuss potential pregnancy and lactation considerations, as safety data are limited. - Avoid abrupt discontinuation to reduce withdrawal phenomena.

Haloperidol may interact with other medicines, influencing its effectiveness or safety profile.

Avoid: - Other dopamine‑blocking agents or high‑potency antipsychotics. - Medications known to prolong the QT interval. - Strong CYP3A4 inhibitors that can increase haloperidol levels.

Use with caution: - CNS depressants such as benzodiazepines or opioids. - Anticholinergic drugs that may mask extrapyramidal symptoms. - Antihypertensive agents, as additive blood‑pressure lowering effects may occur. - Alcohol, which can enhance sedation.